144 related items for PubMed ID: 16848751
1. Cyclosporin-A in the treatment of nephrotic syndrome: the importance of monitoring C0 (trough) and C2 (two hours after its administration) blood levels.
Goumenos DS, Kalliakmani P, Tsakas S, Savidaki I, Vlachojannis JG.
Med Chem; 2006 Jul; 2(4):391-3. PubMed ID: 16848751
[Abstract] [Full Text] [Related]
2. The remission of nephrotic syndrome with cyclosporin treatment does not attenuate the progression of idiopathic membranous nephropathy.
Goumenos DS, Kalliakmani P, Tsakas S, Sotsiou F, Vlachojannis JG.
Clin Nephrol; 2004 Jan; 61(1):17-24. PubMed ID: 14964453
[Abstract] [Full Text] [Related]
3. C1-C2 point monitoring of low-dose cyclosporin a given as a single daily dose in children with steroid-dependent relapsing nephrotic syndrome.
Nakahata T, Tanaka H, Tsugawa K, Kudo M, Suzuki K, Ito E, Waga S.
Clin Nephrol; 2005 Oct; 64(4):258-63. PubMed ID: 16240896
[Abstract] [Full Text] [Related]
4. Effect of cyclosporine therapy with low doses of corticosteroids on idiopathic nephrotic syndrome.
Griveas I, Visvardis G, Papadopoulou D, Nakopolou L, Karanikas E, Gogos K, Stavianoudakis G.
Artif Organs; 2010 Mar; 34(3):234-7. PubMed ID: 20447050
[Abstract] [Full Text] [Related]
5. Is single-daily low-dose cyclosporine therapy really effective in children with idiopathic frequent-relapsing nephrotic syndrome?
Fujinaga S, Ohtomo Y, Someya T, Shimizu T, Yamashiro Y, Kaneko K.
Clin Nephrol; 2008 Feb; 69(2):84-9. PubMed ID: 18218301
[Abstract] [Full Text] [Related]
6. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.
Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
[Abstract] [Full Text] [Related]
7. Long-term results of cyclosporine-induced remission of relapsing nephrotic syndrome in children.
Kim PK, Kim KS, Pai KS, Kim JH, Choi IJ.
Yonsei Med J; 1997 Oct; 38(5):307-18. PubMed ID: 9409194
[Abstract] [Full Text] [Related]
8. Treatment of idiopathic nephrotic syndrome with cyclosporin A in children.
Hamed RM.
J Nephrol; 1997 Oct; 10(5):266-70. PubMed ID: 9364319
[Abstract] [Full Text] [Related]
9. Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome.
Gellermann J, Ehrich JH, Querfeld U.
Nephrol Dial Transplant; 2012 May; 27(5):1970-8. PubMed ID: 21976740
[Abstract] [Full Text] [Related]
10. Cyclosporin A absorption profiles in children with nephrotic syndrome.
Nozu K, Iijima K, Sakaeda T, Okumura K, Nakanishi K, Yoshikawa N, Honda M, Ikeda M, Matsuo M.
Pediatr Nephrol; 2005 Jul; 20(7):910-3. PubMed ID: 15856324
[Abstract] [Full Text] [Related]
11. Significance of combined cyclosporine-prednisolone therapy and cyclosporine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome: a randomized controlled multicenter trial.
Saito T, Iwano M, Matsumoto K, Mitarai T, Yokoyama H, Yorioka N, Nishi S, Yoshimura A, Sato H, Ogahara S, Shuto H, Kataoka Y, Ueda S, Koyama A, Maruyama S, Nangaku M, Imai E, Matsuo S, Tomino Y, Refractory Nephrotic Syndrome Study Group.
Clin Exp Nephrol; 2014 Oct; 18(5):784-94. PubMed ID: 24363128
[Abstract] [Full Text] [Related]
12. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs.
Goumenos DS, Katopodis KP, Passadakis P, Vardaki E, Liakopoulos V, Dafnis E, Stefanidis I, Vargemezis V, Vlachojannis JG, Siamopoulos KC.
Am J Nephrol; 2007 Oct; 27(3):226-31. PubMed ID: 17389782
[Abstract] [Full Text] [Related]
13. Treatment of steroid-resistant nephrotic syndrome with cyclosporine: study of 17 cases and a literature review.
Frassinetti Castelo Branco Camurça Fernandes P, Bezerra Da Silva G, De Sousa Barros FA, Costa Oliveira CM, Kubrusly M, Evangelista JB.
J Nephrol; 2005 Oct; 18(6):711-20. PubMed ID: 16358229
[Abstract] [Full Text] [Related]
14. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
Choudhry S, Bagga A, Hari P, Sharma S, Kalaivani M, Dinda A.
Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
[Abstract] [Full Text] [Related]
15. Combined cyclosporine and prednisolone therapy using cyclosporine blood concentration monitoring for adult patients with new-onset minimal change nephrotic syndrome: a single-center pilot randomized trial.
Shirai S, Imai N, Sueki S, Matsui K, Tominaga N, Sakurada T, Yasuda T, Kimura K, Shibagaki Y.
Clin Exp Nephrol; 2018 Apr; 22(2):283-290. PubMed ID: 28699032
[Abstract] [Full Text] [Related]
16. Cyclosporine C2 monitoring for the treatment of frequently relapsing nephrotic syndrome in children: a multicenter randomized phase II trial.
Iijima K, Sako M, Oba MS, Ito S, Hataya H, Tanaka R, Ohwada Y, Kamei K, Ishikura K, Yata N, Nozu K, Honda M, Nakamura H, Nagata M, Ohashi Y, Nakanishi K, Yoshikawa N, Japanese Study Group of Kidney Disease in Children.
Clin J Am Soc Nephrol; 2014 Feb; 9(2):271-8. PubMed ID: 24262503
[Abstract] [Full Text] [Related]
17. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome.
Alexopoulos E, Papagianni A, Tsamelashvili M, Leontsini M, Memmos D.
Nephrol Dial Transplant; 2006 Nov; 21(11):3127-32. PubMed ID: 16968719
[Abstract] [Full Text] [Related]
18. Initial remission-inducing effect of very low-dose cyclosporin monotherapy for minimal-change nephrotic syndrome in Japanese adults.
Matsumoto H, Nakao T, Okada T, Nagaoka Y, Shino T, Yoshino M, Hidaka H.
Clin Nephrol; 2001 Feb; 55(2):143-8. PubMed ID: 11269678
[Abstract] [Full Text] [Related]
19. Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study (JNSCS).
Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Nitta K, Tsukamoto T, Uchida S, Takeda A, Sato T, Wada T, Hayashi H, Akai Y, Fukunaga M, Tsuruya K, Masutani K, Konta T, Shoji T, Hiramatsu T, Goto S, Tamai H, Nishio S, Shirasaki A, Nagai K, Yamagata K, Hasegawa H, Yasuda H, Ichida S, Naruse T, Nishino T, Sobajima H, Tanaka S, Akahori T, Ito T, Terada Y, Katafuchi R, Fujimoto S, Okada H, Ishimura E, Kazama JJ, Hiromura K, Mimura T, Suzuki S, Saka Y, Sofue T, Suzuki Y, Shibagaki Y, Kitagawa K, Morozumi K, Fujita Y, Mizutani M, Shigematsu T, Kashihara N, Sato H, Matsuo S, Narita I, Isaka Y.
Clin Exp Nephrol; 2020 Jun; 24(6):526-540. PubMed ID: 32146646
[Abstract] [Full Text] [Related]
20. Cyclosporin treatment of glomerular diseases.
Radhakrishnan J, Halevy D.
Expert Opin Investig Drugs; 2000 May; 9(5):1053-63. PubMed ID: 11060727
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
